Ann Dermatol.  2014 Feb;26(1):141-143. 10.5021/ad.2014.26.1.141.

Prominent Alopetic Lesions of Lichenoid Drug Eruption Treated with Topical Tacrolimus

• Cho HK
• Lee SY

• KMID: 2265722
• DOI: http://doi.org/10.5021/ad.2014.26.1.141

Abstract

No abstract available.

MeSH Terms

Drug Eruptions*
Tacrolimus*
Tacrolimus

Reference

1. Na CH, Seo HD, Chung BS, Shin BS. A case of lichenoid drug eruption with whole body and oral mucosal involvement caused by antituberculosis drugs. Korean J Dermatol. 2008; 46:1145–1148.

2. Chang KY, Park HJ, Lim YS, Choi HY, Myung KB. Clinical study and skin tests of patients with drug eruptions. Korean J Dermatol. 1998; 36:997–1004.

3. Powell ML, Ehrlich A, Belsito DV. Lichenoid drug eruption to salsalate. J Am Acad Dermatol. 2001; 45:616–619.

4. Eom SC, Chae YS, Suh KS, Kim ST. The clinical features of lichenoid drug eruption and the histopathologic differentiation between lichenoid drug eruption and lichen planus. Korean J Dermatol. 1994; 32:1019–1025.

5. Lozada-Nur FI, Sroussi HY. Tacrolimus powder in Orabase 0.1% for the treatment of oral lichen planus and oral lichenoid lesions: an open clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 102:744–749.